The Latest Developments in Chronic Myelogenous Leukemia (CML)
From the 2010 American Society of Hematology (ASH) Annual Meeting
Listen Now
Topics Covered
- Overview of CML, including Current Standard of Care
- New Findings Reported at ASH
- How Clinical Trials Contribute to Treatment Options
- Adherence: The Importance of Taking Your Pills on Schedule
- Managing Side Effects
- Communicating with Your Health Care Team
- Quality-of-Life Concerns
- Questions for Our Panel of Experts
Our Panel of Experts
-
Neil P. Shah, MD, PhD
- Assistant Professor, Division of Hematology/Oncology, University of California San Francisco
-
Elias Jabbour, MD
- Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center
-
Richard Dickens, MSW
- Blood Cancers Program Coordinator, Mind/Body/Spirit Project Coordinator, CancerCare
Workshop Date
This workshop was originally recorded on January 13, 2011.